Related Experiment Videos
Dopamine versus dobutamine: are all the facts there?
A H Mutnick1, B Szymusiak-Mutnick, E J Drea
1Department of Pharmacy, Memorial Medical Center, Springfield, Illinois 62781.
Pharmacotherapy
|January 1, 1990
Summary
Dobutamine is increasingly prescribed over dopamine, but evidence supporting its advantages is limited. This review questions the superiority of dobutamine, suggesting potential overuse and increased healthcare costs.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Critical Care Medicine
Background:
- Dobutamine is increasingly prescribed over dopamine in recent years.
- Reported dobutamine advantages include less tachycardia, peripheral vasoconstriction, and reduced intracardiac pressures compared to dopamine.
- This study critically evaluates the evidence supporting these claimed advantages.
Purpose of the Study:
- To review the literature comparing dobutamine and dopamine.
- To identify potential flaws in studies supporting dobutamine's superiority.
- To inform pharmacy departments about potential dobutamine overuse and its impact on healthcare costs.
Main Methods:
- Comprehensive literature review of studies comparing dobutamine and dopamine.
- Critical analysis of study interpretations and findings.
- Examination of evidence for claimed pharmacological advantages.
Main Results:
- Conclusive evidence supporting dobutamine's superiority over dopamine was not found.
- Several studies suggest potential flaws in the interpretation of initial findings.
- The increased use of dobutamine may be based on inconclusive evidence.
Conclusions:
- The perceived advantages of dobutamine over dopamine lack conclusive supporting evidence.
- Potential overuse of dobutamine requires informed and unbiased management by pharmacy departments.
- Addressing potential dobutamine overuse can help mitigate escalating healthcare costs.